|
2024
|
Invention
|
Method for quantifying bound acetate in glycoconjugates. The present invention relates to a metho... |
|
|
Invention
|
Intranasal administration of esketamine.
The present invention is directed to pharmaceutical pro... |
|
|
Invention
|
Forms of aticaprant. The disclosure provides crystalline and amorphous forms of aticaprant. Also ... |
|
|
Invention
|
Fimh mutant, compositions therewith and use thereof.
Polypeptides comprising a FimH lectin domai... |
|
|
Invention
|
Compositions comprising aticaprant. The present disclosure relates to compositions, including ora... |
|
|
Invention
|
Compositions and methods for the treatment of depression. The disclosure provides methods for tre... |
|
|
Invention
|
Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of... |
|
2023
|
Invention
|
Bioconjugate compositions and process for bioconjugate production. The present invention relates ... |
|
|
Invention
|
Multivalent vaccine compositions and uses thereof. Compositions and methods are described for ind... |
|
|
Invention
|
Expec glycoconjugate vaccine formulations.
Compositions and methods for inducing an immune respo... |
|
|
Invention
|
Compositions and methods for enhancing gene expression.
The present disclosure generally relates... |
|
|
Invention
|
Induce and enhance immune responses using recombinant replicon systems.
The present disclosure g... |
|
|
Invention
|
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors. The present in... |
|
|
Invention
|
Esketamine for the treatment of depression.
The present invention provides methods of maintainin... |
|
|
Invention
|
Liposomes containing phosphorylated tau peptides for inducing sustained immune responses.
Method... |
|
|
Invention
|
Fimh mutants, compositions therewith and use thereof.
Polypeptides comprising a FimH lectin doma... |
|
|
Invention
|
Injection device with ergonomic housing form factor.
An injection device comprises a housing hav... |
|
|
Invention
|
Method of safe administration of phosphorylated tau peptide vaccine.
Methods for inducing anti-p... |
|
|
Invention
|
Mrna compositions for inducing latent hiv-1 reversal. The present disclosure includes mRNA compos... |
|
|
Invention
|
Treatment or prevention of dengue viral infection. 1233132331233313231332313233132333. |
|
|
Invention
|
Vial holder. Various exemplary methods, systems, and devices for vial holders are provided. The v... |
|
|
Invention
|
Pure forms of crystalline aticaprant.
The disclosure provides compositions containing pure atica... |
|
|
Invention
|
Pure forms of crystalline aticaprant. The disclosure provides compositions containing pure aticap... |
|
|
Invention
|
Polymorph forms of aticaprant for use in treating major depressive disorder. The disclosure provi... |
|
|
Invention
|
Compositions comprising aticaprant.
The present disclosure relates to compositions, including or... |
|
|
Invention
|
Smart liquid drug administration. In general, devices, systems, and methods of smart liquid drug ... |
|
|
Invention
|
Heterologous administration of tau vaccines.
Methods for inducing an immune response against tau... |
|
|
Invention
|
Recombinant arterivirus replicon systems and uses thereof.
The present disclosure generally rela... |
|
2022
|
Invention
|
Mdr e. coli immunogen.
The subject relates to an isolated antibody that specifically binds to O2... |
|
|
Invention
|
Anti-human vista antibodies and use thereof.
The invention provides antagonistic and agonistic a... |
|
|
Invention
|
Method of safe administration of tau phosphopeptide conjugate.
Methods for inducing anti-phospho... |
|
|
Invention
|
Processes for the preparation of (s)-2-(4-chloro-2-methoxyphenyl)-2-((3 -methoxy-5-(m ethylsulfon... |
|
|
Invention
|
Compositions and methods for the treatment of depression.
The disclosure provides methods for tr... |
|
|
Invention
|
Single vial holder |
|
|
Invention
|
Dual vial holder |
|
|
Invention
|
Process for bioconjugate production.
The present invention relates to a process for the producti... |
|
2021
|
Invention
|
Analytical method for glycogonjugates using a capillary-based immunoassay system.
The invention ... |
|
|
Invention
|
Solid formulation.
The invention relates to pharmaceutical formulations comprising an active pha... |
|
|
Invention
|
Pharmaceutical formulation.
The invention relates to pharmaceutical formulations comprising an a... |
|
|
Invention
|
Variant staphylococcus aureus luka and lukb polypeptides and vaccine compositions.
The present d... |
|
|
Invention
|
Stabilized corona virus spike protein fusion proteins.
The present invention provides stabilized... |
|
|
Invention
|
Stabilized coronavirus spike protein fusion proteins.
The present invention provides stabilized ... |
|
|
Invention
|
Bi- and monocyclic nucleoside analogs for treatment of hepatitis e.
The present disclosure is di... |
|
2020
|
Invention
|
Drug delivery adjustment.
Provided herein are drug administration devices, methods, and systems ... |
|
|
Invention
|
Drug administration device and system for establishing a dosage regimen and compatibility of comp... |
|
2019
|
P/S
|
Pharmaceutical preparations, in particular for the treatment of multiple sclerosis. |
